Clinical trial
A Prospective, Multi-centre, Single-arm Registry to Evaluate the Safety and Performance of Dafodil™ Pericardial Bioprosthesis Series in Participants Undergoing Native/Prosthetic Aortic or Mitral Valve Replacement in Real World Settings
NCT07379112 is registered in ClinicalTrials.gov with Meril Life Sciences Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-centre, Single-arm Registry to Evaluate the Safety and Performance of Dafodil™ Pericardial Bioprosthesis Series in Participants Undergoing Native/Prosthetic Aortic or Mitral Valve Replacement in Real World Settings
- Lead sponsor
- Meril Life Sciences Pvt. Ltd.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- December 1, 2033
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve disease, mitral valve disease, prosthetic heart valve dysfunction, valvular heart disease requiring surgical aortic or mitral valve replacement